Ongoing Tai Chi Training for Children With ADHD
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03434509 |
|
Recruitment Status :
Suspended
(Due to COVID-19, we have suspended enrollment.)
First Posted : February 15, 2018
Last Update Posted : November 23, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Attention Deficit Hyperactivity Disorder (ADHD) has tremendous individual and societal impact, and the effectiveness of current standard treatments is limited. Thus, there are potential public health benefits for novel behavioral training programs that could remediate the core features of ADHD and contribute to sustained improvements in behavioral control. There is mounting evidence that children with ADHD show difficulties with motor control, and that these motor deficits are strongly associated with the core behavioral features of ADHD. Based on this information, the CNIR initiated a feasibility trial of a movement-based intervention, utilizing Tai Chi practice, targeting improved behavioral control through engagement of the motor system and results are highly promising. The investigators therefore will employ an extension of our ongoing Tai Chi programs for children with ADHD, beginning with children who have already completed one of the previous Tai Chi sessions. This program will provide the basis for studying the long-term effects of mindful movement, as well as creating a foundation for exploring the way that such interventions can be expanded into a more realistic support setting for the community.
Hypothesis: After participating in the ongoing Tai Chi program, children with ADHD will show improvements in behavioral measures of motor, cognitive, and attentional control. The investigators further expect movement-based training will result in decreases in ADHD symptom severity.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| ADHD | Other: Continuous Tai Chi and Mindful Movement classes | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 50 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Effects of Ongoing Movement-Based Mindfulness Training for Children With ADHD |
| Actual Study Start Date : | November 2, 2017 |
| Estimated Primary Completion Date : | December 2022 |
| Estimated Study Completion Date : | December 2022 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Tai Chi
Ongoing, continuous Tai Chi and mindful movement instruction, 1 hour, twice per week
|
Other: Continuous Tai Chi and Mindful Movement classes
Participants will be enrolled in ongoing Tai Chi and mindful movement classes throughout the year, for 1 hour twice a week. Class sessions will consist of warm up (yoga- and mindfulness-based practices), postural and breathing exercises, Tai Chi form practice, and Tai Chi games (including push hands). Children on stimulant medications will remain on these medications during the training period (though they will be asked to stop medications one day prior to motor and cognitive testing). Other Names:
|
- Cognitive Motor Control: Response inhibition [ Time Frame: From date of baseline and at every 6 months following, assessed up to 60 months. ]RDoC (research domain criteria) battery for cognitive control targeting response inhibition delivered via laboratory computer (Go/No-Go) examining percentage of error rate and successful inhibition. Significant improvements in response inhibition are expected over the course of the intervention.
- Cognitive Motor Control: Response inhibition [ Time Frame: From date of baseline and at every 6 months following, assessed up to 60 months. ]RDoC (research domain criteria) battery for cognitive control targeting response inhibition delivered via laboratory computer (Flanker) examining percentage of error rate and successful inhibition. Significant improvements in response inhibition are expected over the course of the intervention.
- Cognitive Motor Control: Response inhibition [ Time Frame: From date of baseline and at every 6 months following, assessed up to 60 months. ]RDoC (research domain criteria) battery for cognitive control targeting response inhibition delivered via laboratory computer (Stop-Signal) examining percentage of error rate and successful inhibition. Significant improvements in response inhibition are expected over the course of the intervention.
- Cognitive Motor Control: Response inhibition [ Time Frame: From date of baseline and at every 6 months following, assessed up to 60 months. ]RDoC (research domain criteria) battery for cognitive control targeting response inhibition delivered via laboratory computer (Mirror Tracing Persistence Task) examining percentage of error rate and successful inhibition. Significant improvements in response inhibition are expected over the course of the intervention.
- Cognitive Motor Control: Response inhibition [ Time Frame: From date of baseline and at every 6 months following, assessed up to 60 months. ]RDoC (research domain criteria) battery for cognitive control targeting response inhibition delivered via laboratory computer (DKEFS Trail Making Task) examining percentage of error rate and successful inhibition. Significant improvements in response inhibition are expected over the course of the intervention.
- Behavioral Assessment of Motor Persistence [ Time Frame: From date of baseline and at every 6 months following, assessed up to 60 months. ]Measure of oculomotor persistence and inhibition using the Lateral Gaze Fixation task. Improvements in oculomotor persistence are expected over the course of the intervention.
- Behavioral Assessment of Motor Persistence [ Time Frame: From date of baseline and at every 6 months following, assessed up to 60 months. ]Measure of motor persistence and inhibition using the NEPSY Statue Task ("A Developmental NEuroPSYchological Assessment"). Improvements in motor persistence are expected over the course of the intervention.
- Behavioral Assessments of Motor Overflow [ Time Frame: From date of baseline and at every 6 months following, assessed up to 60 months. ]Measure of motor overflow from the PANESS (Physical and Neurologic Examination of Subtle Signs). Improvements in motor overflow are expected over the course of the intervention.
- Behavioral Assessments of Basic Motor Control [ Time Frame: From date of baseline and at every 6 months following, assessed up to 60 months. ]Measure of motor control from the mABC-2 (Movement Assessment Battery for Children). Improvements in motor control are expected over the course of the intervention.
- Clinical Measure of ADHD Symptom Severity [ Time Frame: From date of baseline and at every 6 months following, assessed up to 60 months. ]The Conners-3 survey (parent and teacher). Improvements on this measure are expected over the course of the intervention. In particular, based on previous findings from the CNIR initiated mindful movement feasibility study, marked improvements on Connors-3 subscales for Inattentiveness and Hyperactivity are expected.
- Clinical Measure of Mindfulness [ Time Frame: From date of baseline and at every 6 months following, assessed up to 60 months. ]The CAMM (Child and Adolescent Mindfulness Measure) will be administered. Improvements on this measure are expected over the course of the intervention.
- Clinical Measure of Quality of Life [ Time Frame: From date of baseline and at every 6 months following, assessed up to 60 months. ]The PedsQL (Pediatric Quality of Life Inventory) (parent and child) will be administered. Improvements on this measure are expected over the course of the intervention.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 8 Years to 15 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Children must meet diagnostic criteria for ADHD, based on information from previous participation in "Movement-Based Mindfulness Training for Children with ADHD: A Feasibility Study." Additionally, children must meet criteria on the parent and teacher Conners-3
- Comorbid oppositional defiant disorder (ODD) and anxiety disorders are permitted
- Stimulants, psychoactive medications, or no medication are allowed
Exclusion Criteria:
- diagnosis of Intellectual Disability, Developmental Language Disorder, Reading Disability, or Autism (screened for using the Social Competence Questionnaire (SCQ)
- neurologic disorder (e.g., epilepsy, cerebral palsy, traumatic brain injury, Tourette Syndrome)
- documented hearing impairment ≥ 25 dB (decibel) loss in either ear.
- a Full Scale IQ (Intelligence Quotient) score on the WISC-IV (Wechsler Intelligence Scale for Children) below 80
- a standard score below 85 on the Word Reading Subtest, regardless of IQ score
- foster care
- Female participants will be excluded if they are pregnant or may be pregnant
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03434509
| United States, Maryland | |
| LEAP Facility at Kennedy Krieger Institute | |
| Baltimore, Maryland, United States, 21211 | |
| Principal Investigator: | Stewart Mostofsky, MD | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. |
| Responsible Party: | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. |
| ClinicalTrials.gov Identifier: | NCT03434509 |
| Other Study ID Numbers: |
IRB00143364 |
| First Posted: | February 15, 2018 Key Record Dates |
| Last Update Posted: | November 23, 2021 |
| Last Verified: | November 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Motor Control Attention Cognitive Control |

